TuHURA Biosciences
HURA
8 hedge funds and large institutions have $190K invested in TuHURA Biosciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
164% more capital invested
Capital invested by funds: $71.9K → $190K (+$118K)
60% more funds holding
Funds holding: 5 → 8 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$57.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.6K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$8.96K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$38.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $63K | +$57.6K | +45 | +643% |
|
|
VF
2
Virtu Financial
New York
| $47K | +$49.9K | +39 | New |
|
|
3
Barclays
London,
United Kingdom
| $25K | -$38.4K | -30 | -59% |
|
|
RE
4
RBC Europe
London,
United Kingdom
| $20.6K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $16K | +$16.6K | +13 | New |
|
|
6
Northern Trust
Chicago,
Illinois
| $9K | +$8.96K | +7 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $6K | +$6.4K | +5 | New |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $3K | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$17K | -26 | Closed |
|
HURA Hedge Fund Activity: Q2 2020 in Review
8 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2020, worth a combined $190K — up 164% from $71.9K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HURA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $57.6K. The largest seller was Barclays, cutting an estimated $38.4K.
- 8 institutional investors held TuHURA Biosciences (HURA) as of Q2 2020, up from 5 in Q1 2020.
- Funds reported $190K of TuHURA Biosciences stock for Q2 2020, up 164% quarter-over-quarter.
- 4 funds opened new TuHURA Biosciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest TuHURA Biosciences buyer in Q2 2020 was Renaissance Technologies, an estimated $57.6K added.
- The largest TuHURA Biosciences seller in Q2 2020 was Barclays, an estimated $38.4K sold.
Based on aggregated 13F filings for Q2 2020.